Ocuphire Pharma Quick Ratio 2010-2024 | IRD
Historical quick ratio values for Ocuphire Pharma (IRD) over the last 10 years.
| Ocuphire Pharma Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2024-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2024-03-31 |
$0.00B |
$0.01B |
0.00 |
| 2023-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2023-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2023-06-30 |
$0.00B |
$0.01B |
0.00 |
| 2023-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2022-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2022-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2022-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2022-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2021-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2021-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2021-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2021-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2020-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2020-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2020-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2020-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2019-12-31 |
$0.00B |
$0.01B |
0.00 |
| 2019-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2019-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2019-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2018-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2018-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2018-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2018-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2017-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2017-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2017-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2017-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2016-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2016-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2016-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2016-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2015-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2015-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2015-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2015-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2014-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2014-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2014-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2014-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2013-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2013-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2013-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2013-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2012-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2012-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2012-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2012-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2011-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2011-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2011-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2011-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2010-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2010-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2010-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2010-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2009-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2009-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2009-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2009-03-31 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.000B |
$0.000B |
|
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|
